ArticleCancer research communications2026

BI 905711, a TRAILR2/CDH17 Bispecific Antibody, Alone or with Chemotherapy for Patients with Advanced Gastrointestinal Cancers: Phase I Study Findings.

James J Harding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.